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Hypothesis: Longitudinal Doppler myocardial imaging (DMI), is useful to examine the effect of clonal VL gene usage on cardiac function in AL 
patients at Day 100 following autologous peripheral blood stem cell transplantation (auto-SCT)
Methods and Results: Study population was 53 AL patients who underwent auto-SCT . Cardiac and hematological biomarkers, and longitudinal 
DMI measures were collected at baseline (pre-SCT) and at Day 100 post-SCT in a subset of 39 AL patients. Patients were divided in 4 groups based 
on clonal VL gene usage: Vκ (n=7) vs Vλ I (n=8) vs Vλ II-III (n=13) vs Vλ VI (n=11). Primary outcome was all-causes death, and during a median 
follow-up of 34 months there were 17 events (32%). Cardiac biomarkers and longitudinal diastolic DMI measures were not significantly different 
at Day 100 post-transplant, while systolic DMI, specifically systolic strain rate (sSR) and strain (sS) were consistently decreased in all groups 
(the decrease was significant in Vλ II-III patients (p < 0.001)). Patients using Vκ and Vλ I gene families had the least degree of LV dysfunction 
by standard echo, sSR and sS following auto-SCT, the highest frequency of hematological response, and the lowest mortality rates (0% and 12%, 
respectively). Patients using Vλ II-III and Vλ VI families had more significant rapid LV impairment by sSR and sS, the lowest hematological response 
rates, and the highest mortality (42% and 45%, respectively, log-rank test comparing survival in patients using Vκ or Vλ-I vs patients using Vλ III or 
Vλ VI families had a p < 0.001 ). Difference in sSR and sS mean of the 6 LV basal segments between pre- and post-SCT were significant predictors 
of death, irrespectively of the specific gene used (HR= 0.1 and 0.1, p=0.007 and 0.009, respectively) .
Conclusions: Clonal VL gene usage may influence LV function following auto-SCT. Longitudinal systolic DMI measures are effective in documenting 
these changes Moreover, Clonal VL gene usage, and difference in sSR and sS mean of LV basal segments between pre- and post-SCT are significant 
prognostic factors in patients with AL.
